Abstract
Evaluation of desired and undesired, biological effects of Manufactured NanoParticles (MNPs) is of critical importance for the future of nanotechnology. Experimental studies, especially toxicological, are time-consuming and costly, calling for the development of efficient computational tools capable of predicting biological events caused by MNPs from their structures and physical chemical properties. This mini-review assesses the potential of modern cheminformatics methods such as Quantitative Structure – Activity Relationship modeling to develop statistically significant and externally predictive models that can accurately forecast biological effects of MNPs from the knowledge of their physical, chemical, and geometrical properties. We discuss major approaches for model building and validation using both experimental and computed properties of nanomaterials. We consider two different categories of MNP datasets: (i) those comprising MNPs with diverse metal cores and organic decorations, for which experimentally measured properties can be used as particles descriptors, and (ii) those involving MNPs possessing the same core (e.g., carbon nanotubes), but different surface-modifying organic molecules, for which computational descriptors can be calculated for a single representative of the decorative molecule. We illustrate those concepts with three case studies for which we successfully built and validated predictive models. In summary, this mini-review demonstrates that, analogous to conventional applications of QSAR modeling for the analysis of datasets of bioactive organic molecules, its application to modeling MNPs that we term Quantitative Nanostructure Activity Relationship (QNAR) modeling can be useful for (i) predicting activity profiles of novel MNPs solely from their representative descriptors and (ii) designing and manufacturing safer nanomaterials with desired properties.
Keywords: Manufactured nanoparticles, QSAR, cheminformatics, nanotoxicity, modeling, virtual screening, Biological Effects, environmental systems, in vivo, proliferation, necrosis, apoptosis assays, ATP depletion
Related Journals
Current Computer-Aided Drug Design
18